Timing of fertility preservation procedures in a cohort of female patients with cancer.

نویسندگان

  • Esther Jenninga
  • Leoni A Louwe
  • Alexander A W Peters
  • Johan W R Nortier
  • Carina G Hilders
چکیده

OBJECTIVE Comparison of time intervals from diagnosis to chemotherapy between patients opting for embryo cryopreservation or ovarian tissue cryopreservation. STUDY DESIGN Retrospective analysis. SETTING University hospital in the Netherlands. PATIENTS AND METHODS Thirty-five female patients undergoing fertility preservation procedures before treatment with chemotherapy for cancer. Embryo cryopreservation was performed in 12 patients and ovarian tissue cryopreservation in 23 patients. We investigated differences in time intervals (from diagnosis to start of chemotherapy) between patients opting for embryo cryopreservation and patients opting for ovarian tissue cryopreservation. We calculated time intervals between the moment of diagnosis, the moment of referral, the moment of consultation, the moment of finishing of the fertility preservation procedure and the start of chemotherapy. RESULTS The median time between diagnosis and referral (median=18 days) and between referral and consultation (median=5 days) was comparable in both groups. A significant difference was found between ovarian tissue cryopreservation and embryo cryopreservation for the time interval between consultation and cryopreservation (p=0.001). Ovarian tissue cryopreservation was completed for half of the patients within 6 days after consultation with the gynecologist, and the hormonal stimulation for embryo cryopreservation was completed for all patients within four weeks (median=18 days), with a median of 11 days of hormonal stimulation. A significant difference was found between ovarian tissue cryopreservation and embryo cryopreservation in the time interval between fertility preservation and start of chemotherapy (median=7 vs 19 days, p=0.019). In sum, the total duration between diagnosis and chemotherapy was significantly shorter for ovarian tissue cryopreservation patients than for embryo cryopreservation patients (median=47 vs 69 days, p=0.042). CONCLUSION Embryo cryopreservation can be performed within the standard timeframe of cancer care in patients with breast cancer receiving adjuvant chemotherapy, but if delay of the start of chemotherapy is harmful, ovarian tissue cryopreservation can be done within one week.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

I-35: Emergency Stimulation for Onco -Fertility Patients

Background Fertility preservation for female cancer patients prior to cancer therapy has emerged as an essential component of comprehensive patient care. In the US, approximately 6% of women diagnosed with invasive cancer between 2007 and 2011 that were under 45 years old. The incidence of cancers in reproductive age women signifies a need for fertility preservation options and this need is inc...

متن کامل

I-22: Fertility Preservation and Ovarian Stimulation in Cancer Patients

Cancer is not uncommon and no longer considered to be an incurable disorder. 10% of cancer cases occur under the age of 45. There is a remarkable improvement in treatment and survival rates. Today women have been delaying initiation of childbearing because the incidence of most cancers increases with age. Delayed childbearing results in more female cancer survivors. As a consequence there is an...

متن کامل

I-33: Current Methods for Fertility Preservation

Background Increasing survival rates in patients who suffer from oncological disease and improvement in reproductive medicine techniques has led to increasing use of different fertility preservation methods. The evidence supporting current and forthcoming options for fertility preservation consisted of two main parts as for female and male. Fertility preservation options for female and male dep...

متن کامل

I-3: Fertility Preservation in Women with Cancer

As the efficacies of anticancer therapies were increase and quite efficient early diagnoses have been taken place in gynecological cancer, increased long-term survival of cancer patients and long-term complications of anticancer treatments are being encountered. The lost of ovarian reserve or function due to gonadal toxicity is the major problem that mainly focused. A wide range of new fertilit...

متن کامل

I-11: Cryopreservation and Utilization of Ovarian Tissue: When, Where and How?

In women, around 10% of cancers occur in those younger than 45 years old. Although aggressive chemotherapy/radiotherapy and bone marrow transplantation can cure more than 90% of girls and young women affected by disorders requiring such treatment, the ovaries are very sensitive to cytotoxic drugs, especially to alkylating agents. Therefore, these treatments can result in premature ovarian failu...

متن کامل

P-222: Ovarian Stimulation for Fertility Preservation in Cancer Patients: A Prospective Study

Background: To determine whether random-start controlled ovarian stimulation (COS), in which a stimulation is performed regardless to day of patient’s menstrual cycle, has similar outcomes in comparison to conventional early follicular phase-start COS for cryopreservation of fertilized oocytes in cancer patients. Materials and Methods: This prospective study was performed at two infertility cen...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • European journal of obstetrics, gynecology, and reproductive biology

دوره 160 2  شماره 

صفحات  -

تاریخ انتشار 2012